58. 肥大型心筋症 Hypertrophic cardiomyopathy Clinical trials / Disease details

臨床試験数 : 126 / 薬物数 : 135 - (DrugBank : 42) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 162

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05182658 (ClinicalTrials.gov)	June 1, 2022	21/12/2021	Empagliflozin in Hypertrophic Cardiomyopathy	The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy	Hypertrophic Cardiomyopathy;Heart Failure	Drug: Empagliflozin 10 MG;Drug: Placebo	Institute of Cardiology, Warsaw, Poland	Medical University of Bialystok;University of Eastern Finland;Amsterdam UMC, location VUmc	Not yet recruiting	18 Years	70 Years	All	250	Phase 3	Poland

First Previous1Next Last